These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 2199432
1. Neurobiology of obsessive compulsive disorder: a possible role for serotonin. Winslow JT, Insel TR. J Clin Psychiatry; 1990 Aug; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432 [Abstract] [Full Text] [Related]
2. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder. Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR. Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636 [Abstract] [Full Text] [Related]
3. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety. Murphy DL, Pigott TA. J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026 [Abstract] [Full Text] [Related]
4. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Zohar J, Insel TR. Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259 [Abstract] [Full Text] [Related]
5. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology. Korff S, Harvey BH. Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714 [Abstract] [Full Text] [Related]
6. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS. J Clin Psychiatry; 1992 Apr; 53 Suppl():17-28. PubMed ID: 1532961 [Abstract] [Full Text] [Related]
13. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature]. Etain B, Bonnet-Perrin E. Encephale; 2001 Apr; 27(3):280-9. PubMed ID: 11488259 [Abstract] [Full Text] [Related]
14. Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder. Koo MS, Kim EJ, Roh D, Kim CH. Expert Rev Neurother; 2010 Feb; 10(2):275-90. PubMed ID: 20136383 [Abstract] [Full Text] [Related]
15. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder. Zak JP, Miller JA, Sheehan DV, Fanous BS. J Clin Psychiatry; 1988 Aug; 49 Suppl():23-9. PubMed ID: 3045108 [Abstract] [Full Text] [Related]
16. Issues in the monopharmacotherapy and polypharmacotherapy of obsessive-compulsive disorder. Laird LK. Psychopharmacol Bull; 1996 Aug; 32(4):569-78. PubMed ID: 8993077 [Abstract] [Full Text] [Related]
17. New pharmacologic approaches to obsessive compulsive disorder. Insel TR. J Clin Psychiatry; 1990 Oct; 51 Suppl():47-51; discussion 56-8. PubMed ID: 2120204 [Abstract] [Full Text] [Related]
18. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation. Goodman WK, McDougle CJ, Price LH, Barr LC, Hills OF, Caplik JF, Charney DS, Heninger GR. Biol Psychiatry; 1995 Aug 01; 38(3):138-49. PubMed ID: 7578657 [Abstract] [Full Text] [Related]
19. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. Benkelfat C, Murphy DL, Zohar J, Hill JL, Grover G, Insel TR. Arch Gen Psychiatry; 1989 Jan 01; 46(1):23-8. PubMed ID: 2910220 [Abstract] [Full Text] [Related]